Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: Attitudes and practice

Internal Medicine Journal

Volumn 44, Issue 1, 2014, Pages 40-49

  Verschuren, E C ^a,c   Ong, D E ^a,d   Kamm, M A ^a,b,e   Desmond, P V ^a   Lust, M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Colitis; Colorectal cancer; Dysplasia; Inflammatory bowel disease; Surveillance

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CHROMOENDOSCOPY; COLITIS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON BIOPSY; COLON CANCER; COLON RESECTION; COLONOSCOPY; DYSPLASIA; FEMALE; GASTROENTEROLOGIST; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL PRACTICE; MIDDLE AGED; PANCOLITIS; PHYSICIAN ATTITUDE; POLYPECTOMY; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTITIS; PROTOCOL COMPLIANCE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SURGEON; TERTIARY CARE CENTER; ULCERATIVE COLITIS; WORKLOAD;

COLITIS; COLORECTAL CANCER; DYSPLASIA; INFLAMMATORY BOWEL DISEASE; SURVEILLANCE;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; BIOPSY; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84892884684     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12285     Document Type: Article

References (48)

1. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006; 23: 1097-1104.
2. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-1233.
3. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359.
4. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012; 143: 382-389.
5. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639-645.
6. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535.
7. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590-1592.
8. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M etal. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-459.
9. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA etal. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004; 53: 1813-1816.
10. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002; 56: 48-54.
11. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R etal. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001; 120: 1356-1362.
12. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA etal. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130: 1030-1038.
13. Choi PM, Nugent FW, Schoetz DJ, Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105: 418-424.
14. Hata K, Watanabe T, Kazama S, Suzuki K, Shinozaki M, Yokoyama T etal. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer 2003; 89: 1232-1236.
15. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711-714.
16. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 1990; 85: 1083-1087.
17. Lutgens MW, Oldenburg B, Siersema PD, van Bodegraven AA, Dijkstra G, Hommes DW etal. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009; 101: 1671-1675.
18. Bell C, Bolin T, Clouston A, Connell W, Ellard K, Kench J etal. Clinical Practice Guidelines for Surveillance Colonoscopy - in adenoma follow-up; following curative resection of colorectal cancer; and for cancer surveillance in inflammatory bowel disease: Cancer Council Australia, Sydney, December 2011.
19. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD etal. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-689.
20. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T etal. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010; 138: 738-745.
21. Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV etal. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc 2006; 63: 558-565.
22. Hurlstone DP, McAlindon ME, Sanders DS, Koegh R, Lobo AJ, Cross SS. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2004; 126: 376-378.
23. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005; 37: 1186-1192.
24. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S etal. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888.
25. Efthymiou M, Taylor AC, Kamm MA. Cancer surveillance strategies in ulcerative colitis: the need for modernization. Inflamm Bowel Dis 2011; 17: 1800-1813.
26. Allen PB, Kamm MA, De Cruz P, Desmond PV. Dysplastic lesions in ulcerative colitis: changing paradigms. Inflamm Bowel Dis 2010; 16: 1978-1983.
27. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51: 123-128.
28. Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ etal. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand. Dis Colon Rectum 2004; 47: 314-322.
29. van Rijn AF, Fockens P, Siersema PD, Oldenburg B. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009; 15: 226-230.
30. Vienne A, Simon T, Cosnes J, Baudry C, Bouhnik Y, Soule JC etal. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther 2011; 34: 188-195.
31. Averboukh F, Ziv Y, Kariv Y, Zmora O, Dotan I, Klausner JM etal. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn's and ulcerative colitis. Colorectal Dis 2011; 13: 1230-1235.
32. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS etal. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103: 1611-1620.
33. Bernstein CN, Weinstein WM, Levine DS, Shanahan F. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995; 90: 2106-2114.
34. Rodriguez SA, Collins JM, Knigge KL, Eisen GM. Surveillance and management of dysplasia in ulcerative colitis. Gastrointest Endosc 2007; 65: 432-439.
35. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 2007; 65: 998-1004.
36. Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004; 60: 334-339.
37. Blonksi W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? Scand J Gastroenterol 2008; 43: 698-703.
38. Subramanian V, Mannath J, Ragunath K, Hawkey CJ. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 304-312.
39. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260.
40. Befrits R, Ljung T, Jaramillo E, Rubio C. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 2002; 45: 615-620.
41. Jess T, Loftus EV, Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC etal. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 2006; 130: 1039-1046.
42. Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003; 52: 1127-1132.
43. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003; 125: 1311-1319.
44. Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007; 25: 657-668.
45. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288-1294; discussion 1488-91.
46. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004; 2: 534-541.
47. Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006; 55: 1151-1155.
48. Kottachchi D, Yung D, Marshall JK. Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital. Can J Gastroenterol 2009; 23: 613-617.